Skip to main content
Log in

Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The secretion and metabolism of endogeneous neurotensin-like immunoreactivities after a test meal were studied in five healthy human subjects. Intact neurotensin and the N-terminal metabolic fragment, neurotensin 1–8, were quantified by radioimmunoassay with C- and N-terminally directed antisera in conjunction with gel filtration of plasma samples obtained at timed intervals. Both C- and N-terminal neurotensin-like immunoreactivities rose after the meal, reaching a plateau level after 20 and 30 min, respectively. During the plateau phase, which lasted for the rest of the experimental period of 180 min, the molar ratio of intact neurotensin to neurotensin 1–8 remained approximately constant at 1∶4.6. Meal-stimulated immunoreactive neurotensin appeared to be metabolized in a manner comparable to that of exogenously infused neurotensin in man. The results suggest that intact neurotensin is secreted at an approximately constant rate during the plateau phase. The relatively low plateau level of neurotensin 1–8, which has a much longer half-life than intact neurotensin in the circulation, implies that only a fraction of the secreted intact neurotensin is metabolized to neurotensin 1–8, indicating the existence of alternative pathways of neurotensin metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carraway R, Leeman SE: The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamus. J Biol Chem 248:6854–6861, 1973

    Google Scholar 

  2. Carraway R, Leeman SE: The amino acid sequence of a hypothalamic peptide, neurotensin. J Biol Chem 250:1907–1911, 1975

    Google Scholar 

  3. Sundler F, Hakansson R, Hammer RA, Alumets, J, Carraway, R, Leeman SE, Zimmerman EA: Immunohistochemical localization of neurotensin in endocrine cells of the gut. Cell Tissue Res 178:313–321, 1977

    Google Scholar 

  4. Holzer P, Bucsics A, Saria A, Lembeck F: A study of the concentrations of substance P and neurotensin in the gastrointestinal tract of various mammals. Neurosciences 7:2919–2924, 1982

    Google Scholar 

  5. Polak JM, Sullivan SN, Bloom SR, Buchan AMJ, Facer P, Brown MR, Pearse AGE: Specific localization of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature 270:183–184, 1977

    Google Scholar 

  6. Hammer RA, Leeman SE, Carraway R, Williams RH: Isolation of human intestinal neurotensin. J Biol Chem 255:2476–2480, 1980

    Google Scholar 

  7. Ferri GL, Adrian TE, Ghatei MA, O'Shaughnesy DJ, Probert L, Lee YC, Buchan AMJ, Polak JM, Bloom SR: Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology 84:777–786, 1983

    Google Scholar 

  8. Blackburn AM, Fletcher DR, Bloom SR, Chritofides ND, Long RG, Fitzpatrick ML, Baron JH: Effect of neurotensin on gastric function in man. Lancet 1:987–989, 1980

    Google Scholar 

  9. Kihl B, Rokaeus A, Rosell S, Olbe L: Fat inhibition of gastric secretion in man and plasma concentration of neurotensin-like immunoreactivity. Scand J Gastroenterol 16:513–526, 1981

    Google Scholar 

  10. Thor K, Rokaeus A, Kager L, Rosell S: [Gln4]-Neurotensin and gastrointestinal motility in man. Acta Physiol Scand 110:327–328, 1980

    Google Scholar 

  11. Calam J, Unwin R, Peart WS: Neurotensin stimulates defecation. Lancet 1:737–738, 1983

    Google Scholar 

  12. Fletcher DR, Blackburn AM, Adrian TE, Chadwick VS, Bloom SR: Effect of neurotensin on pancreatic function in man. Life Sci 29:2157–2161, 1981

    Google Scholar 

  13. Blackburn AM, Fletcher DR, Adrian TE, Bloom SR: Neurotensin infusion in man: Pharmacokinetics and effect on gastrointestinal and pituitary hormones. J Clin Endocrinol Metab 51:1257–1261, 1980

    Google Scholar 

  14. Aronin N, Carraway RE, Ferris CF, Hammer RA, Leeman SE: The stability and metabolism of intravenously administered neurotensin in the rat. Peptides 3:637–642, 1982

    Google Scholar 

  15. Shulkes A, Fletcher DR, Hardy KJ: Organ and plasma metabolism of neurotensin in sheep. Am J Physiol 245:E457-E462, 1983

    Google Scholar 

  16. Lee YC, Allen JM, Uttenthal LO, Walker MC, Shemilt J, Gill SS, Bloom SR: The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma. J Clin Endocrinol Metab 59:45–50, 1984

    Google Scholar 

  17. Mashford ML, Nileson G, Rokaeus A, Rosell S: The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in human. Acta Physiol Scand 104:244–246, 1978

    Google Scholar 

  18. Blackburn AM, Bloom SR: A radioimmunoassay for neurotensin in human plasma. J Endocrinol 83:175–181, 1979

    Google Scholar 

  19. Rosell S, Rokaeus A: The effect of ingestion of amino acids, glucose, and fat on circulating neurotensin-like immunoreactivity (NTLI) in man. Acta Physiol Scand 107:263–267, 1979

    Google Scholar 

  20. Go VLW, Demol P: Role of nutrients in the gastrointestinal release of immunoreactive neurotensin. Peptides 2(Suppl 2):267–269, 1981

    Google Scholar 

  21. Hammer RA, Carraway R, Leeman SE: Elevation of plasma neurotensin-like immunoreactivity after a meal. J Clin Invest 70:74–81, 1982

    Google Scholar 

  22. Shulkes A, Chick P, Wong H, Walsh JH: A radioimmunoassay for neurotensin in human plasma. Clin Chim Acta 125:49–58, 1982

    Google Scholar 

  23. Theodorsson-Norheim E, Rosell S: Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion. Regul Peptides 6:207–218, 1983

    Google Scholar 

  24. Carraway R, Leeman SE: Structure requirements for the biological activity of neurotensin, a new vasoactive peptide.In Peptides: Chemistry, Structure and Biology. R Walter, J Meinhofer (eds). Ann Arbor, Ann Arbor Press, 1975, pp. 679–685

    Google Scholar 

  25. Hammer RA, Leeman SE: Neurotensin: Properties and actions.In Gut Hormones. SR Bloom, JM Polak (eds). Edinburgh, Churchill Livingstone, 1981, pp. 290–311

    Google Scholar 

  26. Theodorsson-Norheim E, Oberg K, Rosell S, Bostrom H: Neurotensin immunoreactivity in plasma and tumor tissue from patients with endocrine tumors of the pancreas and gut. Gastroenterology 85:881–889, 1983

    Google Scholar 

  27. Hunter WM, Greenwood FC: Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194:495–496, 1962

    Google Scholar 

  28. Jorgensen KH, Larsen UD: Purification of125I-glucagon by an ion exchange chromatography. Horm Metab Res 4:223–224, 1972

    Google Scholar 

  29. Theodorsson-Norheim E: Evidence that (Gln4)-neurotensin is the naturally occurring neurotensin in plasma. Peptides 4:543–547, 1983

    Google Scholar 

  30. Wilk S, Orlowski M: Cation-sensitive neutral endopeptidase: Isolation and specificity of the bovine pituitary enzyme. J Neurochem 35:1172–1182, 1980

    Google Scholar 

  31. McDermot JR, Smith AI, Edwardson JA, Griffiths EC: Mechanism of neurotensin degradation by rat brain peptidases. Regul Peptides 3:397–404, 1982

    Google Scholar 

  32. Carraway R, Hammer RA, Leeman SE: Neurotensin in plasma: Immunochemical and chromatographic character of acid/acetone soluble material. Endocrinology 107:400–406, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, Y.C., Allen, J.M., Uttenthal, L.O. et al. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal. Digest Dis Sci 30, 129–133 (1985). https://doi.org/10.1007/BF01308198

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01308198

Keywords

Navigation